Skip to main content
Premium Trial:

Request an Annual Quote

Lion Posts Decreased Revenues, Losses for Q3

NEW YORK, Feb. 27 (GenomeWeb News) - Lion Bioscience today reported decreased revenues and losses for the third quarter of its current fiscal year, which ended Dec. 31.


Revenues fell to €5.8 million ($7.2 million), from €8.7 million during the same quarter a year ago.


Lion's net loss for the quarter narrowed to €6.3 million, from €21.8 million in the same period in 2002.


As of Dec. 31, Lion had cash, cash equivalents, and marketable securities of €48.1 million.


Differences from its preliminary earnings figures, published on Feb. 4, result mainly from currency fluctuation effects, according to the company.


Lion also restated its results for prior fiscal years, reflecting a change in revenue recognition. Under its new accounting practice, the company recognizes revenue from software licenses ratably over the term of the contract, rather than upon delivery of the software.


Click here for the full earnings report.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.